Market Tracker

02/23 5:15pm ET

Abiomed Inc (NASDAQ:ABMD)

268.45
Delayed Data
As of Feb 23
 +4.48 / +1.70%
Today’s Change
114.28
Today|||52-Week Range
274.00
+43.24%
Year-to-Date

Today’s Trading

Previous close263.97
Today’s open265.01
Day’s range261.24 - 268.57
Volume367,297
Average volume (3 months)371,452
Market cap$11.9B
Data as of 4:00pm ET, 02/23/2018

Growth & Valuation

Earnings growth (last year)+37.65%
Earnings growth (this year)+105.34%
Earnings growth (next 5 years)+34.00%
Revenue growth (last year)+35.13%
P/E ratio134.9
Price/Sales12.56
Price/Book25.93

Competitors

 Today’s
change
Today’s
% change
DXCMDexCom Inc-0.04-0.07%
WSTWest Pharmaceutical ...-0.18-0.21%
MASIMasimo Corp+0.66+0.79%
IARTIntegra LifeSciences...+1.14+2.15%
Data as of 4:01pm ET, 02/23/2018

Financials

Last reporting date--
EPS forecast (this quarter)$0.63
Annual revenue (last year)$445.3M
Annual profit (last year)$52.1M
Net profit margin11.70%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Michael R. Minogue
Chief Operating Officer
David M. Weber
Corporate headquarters
Danvers, Massachusetts

Forecasts